RWE AG Rating Reiterated by AlphaValue (RWE)

RWE AG (FRA: RWE)‘s stock had its “buy” rating reaffirmed by investment analysts at AlphaValue in a note issued to investors on Thursday, StockRatingsNetwork reports. They currently have a €35.00 ($45.45) price target on the stock.

RWE AG (FRA: RWE) traded up 0.41% on Thursday, hitting €26.254. RWE AG has a 52-week low of €25.77 and a 52-week high of €36.302. The stock’s 50-day moving average is currently €35.30.

A number of other analysts have also recently weighed in on RWE. Analysts at RBC Capital reiterated an “upgras de ector perform” rating on shares of RWE AG in a research note to investors on Wednesday. They now have a €28.00 ($36.36) price target on the stock. Separately, analysts at Kepler Cheuvreux reiterated a “reduce” rating on shares of RWE AG in a research note to investors on Wednesday, May 29th.

Six research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. RWE AG currently has an average rating of “Hold” and an average price target of €30.50 ($39.61).

RWE AG is a Germany-based electricity and gas company. It diversifies its activities into seven divisions: Germany, which consists of the Power Generation and Sales and Distribution Networks business area; Netherlands/Belgium; Great Britain; The Central Eastern and South Eastern Europe; Renewables; Upstream Gas and Oil, and Trading/Gas Midstream.

Latest News

UnitedHealth Group  Price Target Increased to $300.00 by Analysts at BMO Capital Markets
UnitedHealth Group Price Target Increased to $300.00 by Analysts at BMO Capital Markets
VICI Properties  Lifted to “Buy” at Zacks Investment Research
VICI Properties Lifted to “Buy” at Zacks Investment Research
TJX Companies  Stock Rating Upgraded by ValuEngine
TJX Companies Stock Rating Upgraded by ValuEngine
TransDigm Group  Upgraded by ValuEngine to “Buy”
TransDigm Group Upgraded by ValuEngine to “Buy”
Castlight Health Inc  Given Average Recommendation of “Hold” by Analysts
Castlight Health Inc Given Average Recommendation of “Hold” by Analysts
Relx  Earning Favorable News Coverage, Report Shows
Relx Earning Favorable News Coverage, Report Shows


© 2006-2018 Ticker Report. Google+.